On August 8, Genmab announced its financial results for the first six months of 2024.
On Monday, June 3 Genmab held a review of data presented at ASCO from its mid- to late-stage pipeline.
This meeting was not an official program of the ASCO Annual Meeting.
Genmab will host its 2023 R&D Update and ASH Data Review virtually on Tuesday, December 12, 2023.
This meeting is not an official program of the ASH Annual Meeting.
Genmab announced its financial results for the first nine months of 2023 on November 7, 2023.
On February 22, Genmab announced its full year 2022 financial results.
Genmab hosted its 2022 R&D Update and ASH Data Review on Monday, December 12, 2022.
This meeting was not an official program of the ASH Annual Meeting.
Fireside Chat with Chief Executive Officer, Jan van de Winkel and Chief Financial Officer, Anthony Pagano.
On Aug 10, Genmab announced financial results for the first six months of 2022.
On May 11, Genmab announced financial results for the first three months of 2022.
On February 16, Genmab announced its full year 2021 financial results.